Besides, IPO13 was found to play a critical role in NSCLC progression, which was implied by the proliferation promotion of NSCLC cells in vitro and the influence on tumor growth of an NSCLC cancer model in vivo. The gene discussed is IPO13; the disease is non-small cell lung carcinoma.